19 min listen
ACCEL Lite: Real World Implications of 2021 AHA/ACC Chest Pain Guidelines: Modeling of Deferred Testing Recommendations in the PROMISE Trial
FromACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
ACCEL Lite: Real World Implications of 2021 AHA/ACC Chest Pain Guidelines: Modeling of Deferred Testing Recommendations in the PROMISE Trial
FromACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
ratings:
Length:
15 minutes
Released:
Nov 15, 2022
Format:
Podcast episode
Description
In an effort to limit unnecessary testing and increase diagnostic yield, current major guideline recommendations recommend a risk-based strategy with deferred testing in low-risk patients, catheterization in high risk patients, and selective noninvasive testing for those at intermediate risk. To date, no randomized trial has explored the clinical efficacy and safety of any such strategy. In this interview, Pamela S Douglas MD, MACC and Anthony N. DeMaria MD, MACC discuss Real World Implications of 2021 AHA/ACC Chest Pain Guidelines: Modeling of Deferred Testing Recommendations in the PROMISE Trial. Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL
Released:
Nov 15, 2022
Format:
Podcast episode
Titles in the series (100)
ACCEL Lite: Are Primary Prevention ICDs Still Valuable in NICM?: Current guidelines recommend implantable cardioverter-defibrillators (ICDs) in nonischemic cardiomyopathy (NICM) among patients with heart failure and ejection fraction ≤35%. Should this change? Should cardiac resynchronization therapy pacemakers be... by ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research